Dysregulation of metallothionein and circadian genes in human hepatocellular carcinoma
Authors:
- 20 December 2016
- journal article
- other
- Published by Taylor & Francis in Chronobiology International
- Vol. 34 (2) , 192-202
Abstract
Hepatocellular carcinoma (HCC) is the major threat to human health, and disruption of circadian clock genes is implicated in hepatocarcinogenesis. This study examined the dysregulation of metallothioneins and circadian genes in achieved human HCC (n = 24), peri-HCC tissues (n = 24) as compared with normal human livers (n = 36). Total RNA was extracted and reverse transcribed. Real-time RT-qPCR was performed to determine the expression of genes of interest. The results demonstrated the downregulation of metallothionein-1 (MT-1), MT-2, and metal transcription factor-1 (MFT-1) in human HCC as compared with Peri-HCC and normal tissues. MTs are a biomarker for HCC and have typical circadian rhythms; the expression of major circadian clock genes was also determined. HCC produced a dramatic decrease in the expression of core clock genes, circadian locomotor output cycles kaput (Clock) and brain and muscle Arnt-like protein 1 (Bmal1), and decreased the expression of the clock feedback control genes, Periods (Per1, Per2) and Cryptochromes (Cry1, Cry2). On the other hand, the expression of clock target genes nuclear orphan receptor factor protein (Nr1d1) and D-box-binding protein (Dbp) was upregulated as compared with Peri-HCC and normal livers. Peri-HCC also had mild alterations in these gene expressions. In summary, the present study clearly demonstrated the dysregulation of MTs and circadian clock genes in human HCC, which could provide the information of targeting MT and circadian clock in HCC management.Keywords
Funding Information
- Chinese National Science Foundation (81160415, 81460632)
This publication has 48 references indexed in Scilit:
- Expression of metallothionein‐1 and metallothionein‐2 as a prognostic marker in hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2013
- Diurnal Variation of Hepatic Antioxidant Gene Expression in MicePLOS ONE, 2012
- A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinomaLiver International, 2012
- Genetic Variants in theLEPR,CRY1,RNASEL,IL4, andARVCFGenes Are Prognostic Markers of Prostate Cancer-Specific MortalityCancer Epidemiology, Biomarkers & Prevention, 2011
- RETRACTED: Loss of Metallothionein Predisposes Mice to Diethylnitrosamine-Induced Hepatocarcinogenesis by Activating NF-κB Target GenesCancer Research, 2010
- Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growthJournal of Viral Hepatitis, 2010
- An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 SignatureCancer Research, 2010
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Prevention by melatonin of hepatocarcinogenesis in rats injected with N‐nitrosodiethylamineJournal of Pineal Research, 2007
- Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinomaHepatology Research, 2007